Acta Med. 2011, 54: 163-166
https://doi.org/10.14712/18059694.2016.42
CASE 3-2011: Invasive Mucormycosis (Zygomycosis) after Bone Marrow Transplantation in a 26-Year-Old Man with Relapsing Acute Myeloid Leukaemia
References
1. L, Offidani M, Fianchi L et al. (GIMEMA). Mucormycosis in hematologic patients. Haematologica 2004; 89(2): 207–214.
2. L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould – related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66 (suppl. 1): i5–14.
<https://doi.org/10.1093/jac/dkq437>
3. J, Bouchuiguir-Wafa K, Garbino J. Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Infect Dis. 2010; 14 (suppl. 3): e100–3.
<https://doi.org/10.1016/j.ijid.2009.11.024>
4. SM, Bennett CL, Yarnold PR et al. Breakthrough zygomycosis after voriconazole administration among the patients with hematologic malignancies who receive hematopoietic stem-cell transplant or intensive-chemotherapy. Bone Marrow Transplant 2007; 39: 425–429.
<https://doi.org/10.1038/sj.bmt.1705614>
5. Skiada A, Pagano L, Groll A. et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working group on Zygomycosis between 2005–2007. Clin Microbiol Infect 2011 Jan 2. doi: 10.1111/j.1469-0691.2010.03456.x. [Epub ahead of print].
<https://doi.org/10.1111/j.1469-0691.2010.03456.x>
6. R, Konrad F, Kern J et al. PCR-based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 2005; 58: 1180–1184.
<https://doi.org/10.1136/jcp.2004.024703>
<PubMed>
